0.735
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Premarket
| Volume | 1 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Applied Genetic Technologies Corporation | AGTC | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| 0.00 | 0.0% | 0.735 | 04:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.735 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 1 | 1 | - | 0.58 - 4.21 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 07:37:01 | 1 | $ 0.739 | USD |
Period:
Draw Mode:
Applied Genetic Technologies Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 37.29M | 50.73M | 50.60M | $ 500.00k | $ - | -1.82 | -0.40 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | -3.99k | 0.80% |
Applied Genetic Technolo... News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AGTC Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.8296 | 0.85 | 0.58 | 0.7112665 | 514,271 | -0.0946 | -11.4% |
| 1 Month | 0.87 | 0.9544 | 0.58 | 0.8120223 | 351,686 | -0.135 | -15.52% |
| 3 Months | 1.09 | 1.13 | 0.58 | 0.8941228 | 440,988 | -0.355 | -32.57% |
| 6 Months | 1.90 | 2.825 | 0.58 | 1.40 | 530,262 | -1.17 | -61.32% |
| 1 Year | 4.18 | 4.21 | 0.58 | 2.30 | 571,768 | -3.45 | -82.42% |
| 3 Years | 3.80 | 10.42 | 0.58 | 4.90 | 762,806 | -3.07 | -80.66% |
| 5 Years | 5.40 | 10.42 | 0.58 | 4.86 | 507,180 | -4.67 | -86.39% |
Applied Genetic Technolo... Description
| Applied Genetic Technologies Corp is a clinical-stage biotechnology company that uses a proprietary gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. Its initial focus is in the field of ophthalmology, where it has active clinical trials in X-linked retinitis pigmentosa, achromatopsia (ACHM CNGB3 and ACHM CNGA3), and X-linked retinoschisis. In addition to its clinical trials, company has preclinical programs in optogenetics, adrenoleukodystrophy, which is a disease of the central nervous system, other ophthalmology, and otology indications. The optogenetics program is being developed in collaboration with Bionic Sight. |